+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Valeant Pharmaceuticals International, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Comprehensive Company Business Review


Valeant Pharmaceuticals International, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

The report includes financial and SWOT information, industry analysis, opinions, estimates, Valeant Pharmaceuticals International, Inc. annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Valeant Pharmaceuticals International, Inc. and its competitors. This provides clients with a clear understanding of Valeant Pharmaceuticals International, Inc. position in the Pharmaceuticals and Biotechnology Industry.

Scope

  • The report contains a company’s profile and data about owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • The SWOT-analysis provides information about company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency.
  • It also shows company’s income statement and ratio trend-charts, with balance sheets and cash flows presented on an annual and quarterly basis.
  • Company’s financial ratios are directly compared with those of its competitors through industry averages.
  • The report provides relevant news, an analysis of PR-activity, and stock price movements.
  • The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms.


This product will be delivered within 3-5 business days.

Table of Contents

RESEARCH METHODOLOGYDISCLAIMER
1. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. COMPANY PROFILE
1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. BUSINESS OVERVIEW
2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. SWOT ANALYSIS
3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats
4. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. FINANCIAL ANALYSIS
4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Valeant Pharmaceuticals International, Inc. Direct Competitors
5.2. Comparison of Valeant Pharmaceuticals International, Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Valeant Pharmaceuticals International, Inc. and Direct Competitors Stock Charts
5.4. Valeant Pharmaceuticals International, Inc. Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. Valeant Pharmaceuticals International, Inc. Industry Position Analysis
6. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events